Vorinostat Completed Phase 1 Trials for Regional Neuroblastoma / Localized Unresectable Neuroblastoma / Recurrent Neuroblastoma / Stage 4 Neuroblastoma / Stage 4S Neuroblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01208454Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma